Admission to Trading

Summary by AI BETAClose X

Oxford Biomedica PLC has announced the admission to trading of 92,381 ordinary shares of 50p each on the London Stock Exchange's Main Market. These new shares, which are fungible with existing shares, were allotted under the company's Long Term Incentive Plan, Sharesave Scheme, and Employee Share Option Scheme between January 21, 2026, and March 2, 2026. Following this admission, the total number of ordinary shares in issue for Oxford Biomedica PLC is now 120,873,439.

Disclaimer*

UK 100

Latest directors dealings